AI assistant
INSMED Inc — Director's Dealing 2025
Feb 7, 2025
30150_dirs_2025-02-07_7a1b4935-df7f-42f6-8e39-3ed0152913a8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2025-02-05
Reporting Person: Wise John Drayton (Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-05 | Common Stock | A | 15373 | — | Acquired | 140935 | Direct |
| 2025-02-06 | Common Stock | S | 7910 | $80.90 | Disposed | 133025 | Direct |
| 2025-02-07 | Common Stock | S | 10 | $78.91 | Disposed | 133015 | Direct |
Footnotes
F1: Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions.
F2: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees.
F3: This is the weighted average sales price representing 7,910 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.